Navigation Links
Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
Date:5/22/2013

New York (PRWEB) May 22, 2013

The Conference Forum announced the launch of the 3rd Annual Disruptive Innovations to Advance Clinical Trials conference taking place on September 19-20 at the Fairmont Copley Plaza Hotel in Boston, MA.

Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, Genzyme, Janssen Pharmaceuticals and more share bold approaches to reduce expensive infrastructure, engage patients and generate credible clinical data.

“Disruptive innovation needs to be big, or novel, or it must change the very nature of how we do clinical development,” explains Dr Andreas Koester, VP, Clinical Trial Innovation & External Alliances, Janssen Pharmaceutical, one of the event’s co-chairs.

New sessions for the 2013 event include:
*How Not to Do a Traditional Clinical Trial
*Alternative Clinical Settings: The Walgreens-Novartis Collaboration
*Keynote Fireside Chat with Google Ventures on Disruption in Drug development, New Approaches with Mobile Technologies and the Big Data Revolution
*An Interview Series with Disruptive Thinkers from Medimmune, VA Boston Healthcare and the Center for Connected Health

“We are particularly excited to welcome Zen Chu, Faculty Director and Entrepreneur-In-Residence from MIT to present the results of a hackathon on the topic of clinical trials, and Dr John J. Whyte, Chief Medical Expert & VP, Health and Medical Education at Discovery Channel for the interview series,” explains Valerie Bowling, Event Director.

The event expects to attract over 300 disruptive thinkers from pharmaceutical, biotech and technology companies seeking disruptive ideas to change the pace of clinical trials.

For more information, visit http://www.theconferenceforum.org.

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10750006.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. uniQure Named to MIT Technology Reviews 2013 50 Disruptive Companies List Recognizing Worlds Most Innovative Companies
2. BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
3. DuPont Celebrates Scientific Innovation by Recognizing Young Professors
4. SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions
5. Kitware to Enhance the Visualization Toolkit (VTK) to Accelerate Community-Driven Medical Innovation
6. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
7. Global CEO Initiative on Alzheimers Disease (CEOi) Commits Industry to Innovation and Leadership in the Global Fight Against Alzheimers and Dementia
8. Nominations Open for the Inaugural Harrington Prize for Innovation in Medicine
9. Tata Partners with Tel Aviv University to Fund Leading Edge Innovations for Accelerated Commercialization
10. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
11. Selexis SA to Speak on Next Generation Innovations for Secretion Bottlenecks at the 2013 Protein Engineering Summit (PEGS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):